United States Federal Circuit
Hoffmann - LA Roche Inc. v. Apotex Inc., 2013-1161
Summary judgment in favor of defendant generic drug companies of invalidity as to claims 1-8 of plaintiff's '634 patent and claims 1-10 of plaintiff's '957 patent directed to methods of treating osteoporosis, is affirmed, where the district court properly concluded that the claims at issue would have been obvious in light of the prior art and are therefore invalid.
Appellate Information
- Decided 04/11/2014
- Published 04/11/2014
Judges
- BRYSON
Court
- United States Federal Circuit